Prospective Epidemiologic Study of Novel Etiologic Agents of Pelvic Inflammatory Disease

盆腔炎新病因的前瞻性流行病学研究

基本信息

项目摘要

Haggerty, Catherine L. Project Abstract Pelvic Inflammatory Disease (PID) is the frequent infection and inflammation of the upper genital tract among young women that often results in infertility, chronic pelvic pain, and recurrent PID. PID is a recognized complication of Chlamydia trachomatis and Neisseria gonorrhoeae infections, yet up to 70% of cases are idiopathic. An association between bacterial vaginosis (BV) and PID is recognized, however few studies have examined the specific vaginal bacteria most linked to PID, particularly focusing on vaginal bacteria that may resist lab cultivation. Cross-sectional evidence implicates Mycoplasma genitalium (MG) and the protozoan Trichomonas vaginalis (TV) as potential causes of PID, but prospective studies are lacking. We propose a prospective cohort study of 1,199 women considered at high risk for sexually transmitted infection who were actively followed three years for PID development. We will develop and apply to samples a panel of quantitative (qPCR) assays for suspect pathogens, including newly identified BV-associated bacteria, MG, and TV based on our pilot studies and broad-range 16S rRNA gene PCR with next generation sequencing and shotgun sequencing in the discovery phase. We will apply the NanoString nCounter inflammation panel to endometrial samples to determine whether particular inflammatory genes are overexpressed in samples from women with PID compared to women without PID in a bacterial species-specific fashion. We will complement our human studies with fallopian tube and endometrial organoid models, allowing us to directly assess how candidate pathogens interact with tissues of the female upper reproductive tract to induce inflammation. Our aims are to: 1) Develop a panel of candidate microbes for the prediction of PID using broad-range 16S rRNA gene PCR with high throughput sequencing (bacteria) and metagenomics shotgun sequencing (all microbes); 2) Determine whether the presence and quantity of vaginal pathogens in our candidate panel are associated with incident PID using sensitive qPCR, and whether the presence of these candidate pathogens in endometrial tissue is associated with an inflammatory gene signature in patients with PID; 3) Develop a model for the prediction of PID; 4) Determine the population attributable fraction (PAF) of PID due to each pathogen in our panel, CT, and NG; and 5) Determine the inflammatory potential of candidate PID pathogens in fallopian tube and endometrial organoid culture models where microbes are inoculated and inflammatory gene expression is assessed. This will be the first prospective study of PID to apply state-of-the-art qPCR assays and vaginal microbiome profiling, creating the potential for pathogen discovery and imparting a greater understanding of PID etiology. Further, we propose the first study to use fallopian tube organoids and NanoString technology to study PID. Testing for non-gonococcal, non-chlamydial pathogens is not routine, and knowledge gained from our study may identify novel diagnostic targets for PID with the potential to optimize future diagnostic, preventive, and treatment approaches.
作者:Catherine L. 项目摘要 盆腔炎是一种常见的上生殖道感染和炎症。 年轻女性往往会导致不孕、慢性盆腔疼痛和反复发作的盆腔疼痛。PID是公认的 沙眼衣原体和淋球菌感染的并发症,但高达70%的病例是 特发性的。细菌性阴道病(BV)和产后出血之间的联系已被认识到,然而很少有研究 检查了与产后应激障碍最相关的特定阴道细菌,尤其是可能 抵制实验室培养。横断面证据表明生殖支原体(MG)和原生动物有关 阴道毛滴虫(TV)是PID的潜在原因,但缺乏前瞻性研究。 我们建议对1199名被认为是性传播高危人群的女性进行前瞻性队列研究 感染者积极随访3年,发展为盆腔炎。我们将开发并应用于样品a 可疑病原体的定量(QPCR)分析小组,包括新发现的BV相关细菌, MG和TV,基于我们的先导研究和大范围16S rRNA基因聚合酶链式反应和下一代测序 以及发现阶段的鸟枪测序。我们将应用NanoStringnCounter炎症面板 以确定特定的炎症基因在子宫内膜样本中是否过度表达 PID患者与无PID患者相比,在细菌种类上具有特异性。我们将互为补充 我们对输卵管和子宫内膜器质性模型的人体研究,使我们能够直接评估 候选病原体与女性上生殖道组织相互作用,引起炎症。我们的 目的是:1)利用广谱的16S rRNA建立一组可用于预测产后出血的候选微生物 高通量测序的基因聚合酶链式反应(细菌)和元基因组鸟枪法测序(所有微生物); 2)确定我们候选小组中阴道病原体的存在和数量是否相关 使用敏感的定量聚合酶链式反应,以及这些候选病原体在 子宫内膜病变患者的子宫内膜组织与炎性基因信号有关;3)建立模型 4)确定每个病原体引起的细菌感染的群体归因分数(PAF) 在我们的小组中,CT和NG;以及5)确定输卵管内候选PID病原体的炎症潜在性 接种微生物和炎性基因的管状和子宫内膜器质性培养模型 表达被评估。 这将是首次应用最先进的定量聚合酶链式反应分析和阴道微生物组技术对产后出血进行前瞻性研究。 分析,创造发现病原体的可能性,并使人们更好地了解产后出血的病因学。 此外,我们还提出了首次利用输卵管器质和纳米线技术来研究输卵管妊娠的研究。 对非淋球菌、非衣原体病原体的检测并不是常规的,从我们的研究中获得的知识可能 确定新的诊断目标,以优化未来的诊断、预防和治疗 接近了。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DAVID Neal FREDRICKS其他文献

DAVID Neal FREDRICKS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DAVID Neal FREDRICKS', 18)}}的其他基金

Fecal Microbiota Transplantation and Fiber for the Treatment of Graft-versus-host Disease After Hematopoietic Cell Transplantation
粪便微生物群移植和纤维治疗造血细胞移植后移植物抗宿主病
  • 批准号:
    10737446
  • 财政年份:
    2023
  • 资助金额:
    $ 82.46万
  • 项目类别:
ANAEROBE 2022: the 16th Biennial Congress of the Anaerobe Society of the Americas (ASA)
厌氧菌 2022:第 16 届美洲厌氧菌协会 (ASA) 双年度大会
  • 批准号:
    10464618
  • 财政年份:
    2022
  • 资助金额:
    $ 82.46万
  • 项目类别:
Prospective Epidemiologic Study of Novel Etiologic Agents of Pelvic Inflammatory Disease
盆腔炎新病因的前瞻性流行病学研究
  • 批准号:
    10668432
  • 财政年份:
    2020
  • 资助金额:
    $ 82.46万
  • 项目类别:
Prospective Epidemiologic Study of Novel Etiologic Agents of Pelvic Inflammatory Disease
盆腔炎新病因的前瞻性流行病学研究
  • 批准号:
    10220681
  • 财政年份:
    2020
  • 资助金额:
    $ 82.46万
  • 项目类别:
The Gut Microbiota and Graft versus Host Disease (GVHD)
肠道微生物群和移植物抗宿主病 (GVHD)
  • 批准号:
    10593458
  • 财政年份:
    2017
  • 资助金额:
    $ 82.46万
  • 项目类别:
The Gut Microbiota and Graft versus Host Disease (GVHD)
肠道微生物群和移植物抗宿主病 (GVHD)
  • 批准号:
    10287495
  • 财政年份:
    2017
  • 资助金额:
    $ 82.46万
  • 项目类别:
The Gut Microbiota and Graft versus Host Disease (GVHD)
肠道微生物群和移植物抗宿主病 (GVHD)
  • 批准号:
    10053303
  • 财政年份:
    2017
  • 资助金额:
    $ 82.46万
  • 项目类别:
Male urethritis: Novel etiologies and natural history
男性尿道炎:新的病因和自然史
  • 批准号:
    8672151
  • 财政年份:
    2014
  • 资助金额:
    $ 82.46万
  • 项目类别:
Male urethritis: Novel etiologies and natural history
男性尿道炎:新的病因和自然史
  • 批准号:
    9001246
  • 财政年份:
    2014
  • 资助金额:
    $ 82.46万
  • 项目类别:
Male urethritis: Novel etiologies and natural history
男性尿道炎:新的病因和自然史
  • 批准号:
    8815259
  • 财政年份:
    2014
  • 资助金额:
    $ 82.46万
  • 项目类别:

相似海外基金

Maturation and resolution of Staphylococcus aureus skin abscess
金黄色葡萄球菌皮肤脓肿的成熟和消退
  • 批准号:
    MR/Y000447/1
  • 财政年份:
    2024
  • 资助金额:
    $ 82.46万
  • 项目类别:
    Fellowship
S. aureus virulence factor expression during kidney abscess formation
肾脓肿形成过程中金黄色葡萄球菌毒力因子的表达
  • 批准号:
    10610817
  • 财政年份:
    2022
  • 资助金额:
    $ 82.46万
  • 项目类别:
S. aureus virulence factor expression during kidney abscess formation
肾脓肿形成过程中金黄色葡萄球菌毒力因子的表达
  • 批准号:
    10370868
  • 财政年份:
    2022
  • 资助金额:
    $ 82.46万
  • 项目类别:
Characterization of T7SS in S. intermedius isolated from brain abscess to blood-brain barrier disruption
从脑脓肿分离到血脑屏障破坏的中间链球菌中 T7SS 的特征
  • 批准号:
    20K16257
  • 财政年份:
    2020
  • 资助金额:
    $ 82.46万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Optical property measurement in human abscess cavities for photodynamic therapy treatment planning
人体脓肿腔光学特性测量,用于光动力疗法治疗计划
  • 批准号:
    10385790
  • 财政年份:
    2020
  • 资助金额:
    $ 82.46万
  • 项目类别:
Optical property measurement in human abscess cavities for photodynamic therapy treatment planning
人体脓肿腔光学特性测量,用于光动力疗法治疗计划
  • 批准号:
    10025874
  • 财政年份:
    2020
  • 资助金额:
    $ 82.46万
  • 项目类别:
Optical property measurement in human abscess cavities for photodynamic therapy treatment planning
人体脓肿腔光学特性测量,用于光动力疗法治疗计划
  • 批准号:
    10190942
  • 财政年份:
    2020
  • 资助金额:
    $ 82.46万
  • 项目类别:
Combinational therapy with antibiotics and antibiotic-loaded adipose-derived stem cells reduce abscess formation in implant-related infection in rats
抗生素和负载抗生素的脂肪干细胞联合治疗可减少大鼠植入相关感染中脓肿的形成
  • 批准号:
    20K18057
  • 财政年份:
    2020
  • 资助金额:
    $ 82.46万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Optical property measurement in human abscess cavities for photodynamic therapy treatment planning
人体脓肿腔光学特性测量,用于光动力疗法治疗计划
  • 批准号:
    10611934
  • 财政年份:
    2020
  • 资助金额:
    $ 82.46万
  • 项目类别:
Exploratory research for new methodology of diagnosis and treatments of gynecological pelvic abscess using MR Spectroscopy and Identification of bacteria species by NGS.
使用磁共振波谱和NGS鉴定细菌种类的妇科盆腔脓肿诊断和治疗新方法的探索性研究。
  • 批准号:
    18K16779
  • 财政年份:
    2018
  • 资助金额:
    $ 82.46万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了